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Introduction 15
The covalent addition of ubiquitin to proteins is a widespread, highly regulated post-16 translational modification. The Ubiquitin-Proteasome System (UPS) is best known for its ability 17 to target specific proteins for degradation, but ubiquitylation also regulates protein localization, 18 activity and function independently of degradation 1,2,3 . Ubiquitin contains seven lysine residues, 19 each of which can be conjugated further with additional ubiquitin moieties to form polyubiquitin 20 chains of different topologies that may result in different fates 4 . For example, lysine-63 linked 21 chains promote non-degradative functions such as DNA repair or endocytosis 5,6 , while lysine-48 22 linked chains and branched chains such as K11/K48 or K29/K48 promote degradation by the 23 proteasome 7 , a vital process that contributes to cellular homeostasis. 24
Ubiquitin is covalently attached to substrates via a cascade of E1-E2-E3 enzymes 8 . In 25 contrast, deubiquitylating enzymes (DUBs) catalyze ubiquitin removal 9 . As such, a substrate's 26 ubiquitylation status is a product of a carefully tuned balance between ubiquitylation and 27 deubiquitylation activities. By counteracting substrate ubiquitylation, DUBs can rescue proteins 28 targeted to proteasomal destruction. The human genome encodes approximately 100 DUBs, 29 divided into two families: the zinc metalloprotease class (10 DUBs), and the cysteine-protease 30 class that contains most other DUBs (~90) 10, 11 . A small number of DUBs have been well-studied, 31 with many characterized substrates, but most DUBs still do not have any known substrates, 32 limiting our understanding of how DUB substrate specificity is achieved. DUB specificity is 33 complex, as it can arise through binding specificity mediated by unique protein-protein 34 interaction domains 12 , or through recognition of specific topologies of ubiquitin chains 13,14,15 . 35 Most DUB substrates have been discovered by first identifying proteins that interact with 36 3 specific DUBs. This approach has been used globally 16 , but it may miss substrates that interact 37 weakly with DUBs or identify regulators or scaffold proteins rather than true substrates. 38
Identifying physiological UPS substrates, such as DUB targets, is challenging due to the 39 prominence of protein-quality control pathways that ubiquitylate newly synthesized proteins that 40 do not fold properly in growing cells 17 . Therefore, it can be difficult to discern which 41 ubiquitylation or degradation events are physiologically relevant, and which are simply a result 42 of misfolding during protein biogenesis. In addition, because DUBs may function 43 redundantly 18, 19 , inactivating a single DUB may not destabilize its substrates or affect a particular 44 biological process. Consistent with the presence of functional redundancy between DUBs, only 45 the metallo-protease RPN11 is essential for viability in yeast 20 . In the case of proteome stability, 46 it is not known which DUBs have the broadest impact in rescuing proteins from proteasome 47 degradation or to what extent DUBs act redundantly in this process. Identifying the DUBs that 48 have a major role in counteracting proteasomal degradation is of therapeutic interest, because the 49 UPS targets for destruction misfolded, damaged proteins and proteins involved in a wide range 50 of diseases 21 . Inhibiting DUBs that target these proteins may accelerate their elimination to 51 provide a therapeutic benefit. 52 were cysteine-protease DUBs (Table S1, S2) that are likely direct targets of UbVS. All known 83 classes of cysteine-protease DUBs were found ( Fig. 1c , Table S1 ), whereas metallo-protease 84 DUBs (JAMM) were not identified, as expected 23 . Prior proteomic analysis of Xenopus extract 85 detected 54 DUBs 24 (Table S1) , 51 of which were cysteine-proteases. Thus, 10 µM HA-UbVS 86 labeled 35 of 51 (69%) of cysteine-protease DUBs present in extract, consistent with broad 87 specificity of UbVS for this class of DUBs 23 . The remaining DUBs were likely not either 88 because they were present in low abundance or because they do not react rapidly with UbVS. 89
Our HA-UbVS pull-down also isolated proteins that are likely to associate very tightly with 90
DUBs (Table S2) , due to us carrying out the pull-down in presence of high salt (500 mM). A 91 large number of these proteins (31) are components of the proteasome, consistent with the 92 known interaction of UbVS-sensitive DUBs UCHL5 and USP14 25 with the proteasome. Other 93 known interactors of DUBs that we isolated included GBP1/GBP2, which binds USP10 26 , and 94 the SPATA proteins (SPATA2/SPATA2L), which have been identified as CYLD interactors 16 in 95 human cells (Table S2 ), suggesting evolutionary conservation of these interactions. 96 97
UbVS treatment induces degradation of a limited set of proteins in Xenopus extract when 98 available ubiquitin is restored 99
We first wanted to investigate how inhibition of multiple DUBs influenced stability of 100 the proteome in Xenopus extract. We hypothesized that simultaneous inhibition of 35 DUBs with 101
UbVS might lead to destabilization of proteins that require ongoing deubiquitylation to maintain 102 their stability. By simultaneously inhibiting a large number of DUBs, we predicted that we might 103 be able to identify new substrates of DUBs, including substrates whose stability is conferred by 104 the action of redundant DUBs. We used a multiplexed Tandem Mass Tag (TMT)-based 105 6 quantitative proteomics approach 27 ( Fig. 1d ) and we measured protein abundance over time in 106 untreated extract, as well as extract to which ubiquitin, UbVS or the combination 107 (UbVS/ubiquitin) were added ( Fig. 1e ). Proteins decreasing specifically in the presence of UbVS 108 and/or UbVS/ubiquitin may normally be protected from degradation by UbVS-sensitive DUBs. 109
We performed 2 independent experiments using Xenopus extract prepared from 2 sets of eggs 110 (collected from different animals and processed separately), to ensure reproducibility. In each 111 experiment we quantified around 8000 proteins, with an overlap of 94.8% between the 2 112 experiments. 113
First, we observed that in the absence of any perturbation, the proteome was stable in 114
Xenopus extract over the course of 60 minutes ( Fig. S1a ). Few proteins changed in abundance 115 over time and none reproducibly in both the experiments. This degree of proteome stability is 116 consistent with the idea that bulk rates of translation are relatively quiescent in the Xenopus 117 system 28 and that the extract was treated with cycloheximide to prevent protein synthesis and 118 mitotic entry. Proteome stability in untreated extract was not a consequence of limiting ubiquitin 119 availability because addition of exogenous ubiquitin alone did not stimulate protein degradation 120 ( Fig. S1a ). With the exception of ubiquitin, which was added to the extract, we did not observe 121 any proteins that increased in abundance ( Fig. S1a ) in both the experiments. Addition of UbVS 122 alone also had no measurable effect on protein stability, possibly due to depletion of available 123 ubiquitin ( Fig. S1a ). However, addition of UbVS together with ubiquitin (UbVS/ubiquitin) 124 induced degradation of 34 proteins, as defined by a reduction in their abundance by at least 1.5-125 fold in both experiments ( Fig. 1f, g) . Choosing a more relaxed threshold based on the 5% of 126 proteins whose abundance decreased most in UbVS/ubiquitin (FDR 2%) revealed additional 127 proteins that decreased in both experiments ( Fig. S3a ). Because transcription and translation 128 7 were inactive in extract, the decrease in protein abundance of this specific set of proteins was 129 likely a consequence of protein degradation that occurred as a direct consequence of DUB 130 inhibition. Thus, these proteins represent putative DUB substrates that are protected from 131 degradation by UbVS-sensitive DUBs. 132
Because only a limited number of proteins were destabilized by the addition of 10 µM 133
UbVS/ubiquitin, we tested whether stronger inhibition of UbVS-sensitive DUBs, by addition of a 134 higher concentration of UbVS, led to destabilization of a larger number of proteins. We 135 compared protein stability in untreated extract and in extract co-treated with ubiquitin and 10 µM 136 (as in the previous experiments) or 30 µM UbVS ( Fig. S2a ) using TMT-based quantitative 137 proteomics as before. We confirmed the degradation of the proteins observed previously using 138 10 µM UbVS, but we did not observe an increase in the number of proteins degraded in the 139 presence of 30 µM UbVS (Fig. S2b ). On the contrary, the proteins decreasing in 10 µM UbVS 140 were more stable at the higher UbVS concentration ( Fig. S2b, S2c ). This finding suggested that 141 addition of a higher concentration of UbVS might lead to faster ubiquitin depletion, thereby 142 hampering the ability of UbVS to stimulate protein degradation. To test this hypothesis, we 143 monitored the discharge rate of the E2-Ub thioester after ubiquitin addition to extract pre-treated 144 with increasing concentrations of UbVS. Whereas addition of 50 µM ubiquitin was sufficient to 145 completely sustain Ube2C charging for 30 minutes in extract treated with 10 µM UbVS, this 146 concentration of ubiquitin was insufficient to maintain the E2 charged in extract treated with 147 higher concentration of UbVS ( Fig. S2d ). Thus, we cannot drive broader protein instability by 148 stronger DUB inhibition because ubiquitin becomes depleted too rapidly. 149
Confirmation of UbVS-dependent proteasomal degradation of the newly identified 150 substrates with human orthologs 151
Most of the 34 substrates that we identified have reported physiological functions, but 152 only 9 are known UPS substrates ( Fig. 2a, Fig. S3a , Table S3 ). Furthermore, for only four of 153 them have specific DUBs been identified that control their stability. Two of these proteins are 154 ubiquitin ligases, MARCH7 and BIRC3, which are known to be protected from degradation by 155 cysteine-protease DUBs in human cells (by USP7 or USP9 29 and USP19 respectively 30 ). In 156 addition, we identified Stam and NFX1, which are known to be deubiquitylated by the cysteine-157 protease DUBs USP8 31 and USP9 respectively 32 . The ability of our screen to identify known 158 DUB substrates suggests that our approach is capable of identifying physiologically relevant 159 proteins whose stability requires DUB activity. 160
For the majority of the proteins we identified, DUBs have not been implicated in 161 regulation of their stability. We identified four additional ubiquitin ligases (MKRN1, RNF138, 162 ZNF598, UBOX5), whose stability is not known to be dependent on DUB activity. This 163 enrichment for ubiquitin ligases is again consistent with the fact that DUBs are known to protect 164 them from auto-ubiquitination and consequent degradation 17,33 . Other functional classes of 165 proteins that we identified included transcriptional regulators (GTSF1, SOX3, SOX15, TGIF2), 166 signaling proteins (GYGIf1, PLK3, WEE2, CSNK1E, BORA, PIM3), cytoskeletal regulators 167 (CRIPT, WASL, KIAA1430, HN1, ARHGEF19), proteins involved in RNA processing 168 (FAM32, RNASEH1, RBM18, SYF2, ZMAT22, ZFP36L11, EIF1), DNA damage components 169 (ETAA1, SPRTN), a lipid storage protein (PLIN2), and an uncharacterized protein (C6ORF132). 170
Together these findings suggest that ongoing deubiquitylation in the Xenopus system is 171 important to maintain the stability of proteins that regulate a wide variety of biological processes. 172
We looked for possible characteristics sequence characteristics of these substrates (Table  173 S3) that could contribute to their recognition by the UPS. Consistent with the PEST sequence 34 174 9 being a signal that promotes ubiquitin and proteasome-dependent degradation, we found one or 175 multiple PEST sequences in 13 of the 34 hits (Table S3 ). Because efficient protein degradation 176 by the proteasome requires unstructured regions in its substrates 35 , we analyzed their sequences 177 using ProViz 36 . We found that 8 substrates were predicted to be completely or highly disordered 178 whereas 25 had significantly disordered regions consistent with the possibility that they are 179 proteasome substrates (Table S3) . 180
To directly test whether degradation of the identified DUB substrates was proteasome-181 dependent, we quantified protein stability in extract treated with UbVS/ubiquitin in the presence 182 of the proteasome inhibitor MG262 or DMSO (as a control) with a TMT-based quantitative 183 proteomics experiment ( Fig. S4a, S4b ). We found that 19 proteins became unstable after 184
UbVS/ubiquitin addition ( Fig. S4b, S4c ), 14 of which were among the 34 substrates identified 185 ( Fig. 1g ). All of these proteins were stabilized by proteasome inhibition (Fig. S4b, c) . Thus, 186
UbVS-sensitive DUBs antagonize proteasome-mediated degradation of these proteins. 187
To verify the findings of the proteomic experiments and directly test whether these 188 proteins become destabilized by DUB inhibition, we expressed 13 candidate substrates in rabbit 189 reticulocyte lysate and labeled them with 35 S-methionine. We chose ten proteins from our list of 190 34 candidates, as well as three proteins that were destabilized in at least one of the two 191 experiments of Fig.1f . We translated in vitro human orthologs, with the exception of PIM3, 192
where we tested the Xenopus protein. Subsequently, we added the translated proteins to untreated 193 extract or to extract pre-treated with ubiquitin, UbVS or UbVS/ubiquitin and monitored their 194 stability over time. We found that 12/13 proteins were degraded in the presence of 195 UbVS/ubiquitin but were stable in the other conditions ( Fig. 2b, 2c and Fig. S3b, 3c ). STAM was 196 the only protein that was not destabilized in the presence of UbVS/ubiquitin, but instead showed 197 10 strong poly-ubiquitination ( Fig. 2d ). As a control, two proteins that were stable in the proteomic 198 experiments (KPNA2 and HSPA8), were also tested and found to be stable when assayed by this 199 approach (Fig. 2b, 2c ) Thus, because we could recapitulate the behaviour of the endogenous 200
Xenopus proteins using human orthologs, the DUB-dependent regulation of these proteins is 201 likely conserved, as is known already for MARCH7, BIRC3, NFX1 and STAM. 202
Identification of DUBs sufficient to rescue proteins from degradation in UbVS/ubiquitin-203 treated extract 204
Next, we used these substrates to investigate the role of cysteine-protease DUBs in 205 counteracting their proteasomal degradation. If the proteins degraded in UbVS/ubiquitin-treated 206 extract were true DUB substrates, addition of recombinant DUBs to the extract should be able to 207 rescue their degradation. Furthermore, by testing the sufficiency of each DUB to rescue 208 degradation of these substrates, we can evaluate the activity and specificity of each DUB, even if 209 they normally function redundantly. We reasoned that the DUBs efficiently targeted by UbVS 210 were most likely to rescue the stability of the proteins degraded. Thus, we measured the fraction 211 of each DUB labeled by UbVS. After we treated the extract with 10 µM HA-UbVS, we 212 subsequently depleted all the HA-UbVS (and associated proteins) from the extract by 213 immunodepletion with anti-HA antibodies coupled to beads. Using TMT-based quantitative 214 proteomics, we compared the proteins remaining in extract after immunodepletion of HA-UbVS 215 to the proteins present in extract after incubation with empty beads. As expected, the proteins 216 depleted were mostly DUBs ( Fig. S5a ). We detected 32 cysteine-protease DUBs in undepleted 217 extract and found that 25 of them were depleted by HA-UbVS ( Fig. 3a) , with 19 DUBs being 218 depleted by at least 30%. There was no clear correlation between the reported abundance 24 of the 219 DUBs in extract (Table S1 ) and their fractional depletion by HA-UbVS ( Fig. 3a ). We selected 12 220 11 DUBs that were depleted at least 30% to test if they could rescue substrate degradation in 221 UbVS/ubiquitin treated extract ( Fig.3b, in bold) . In addition, we tested USP14 because it can 222 rescue several substrates from proteasomal degradation 37 , as well as USP21 because it is a highly 223 active and non-specific DUB widely used in in vitro assays. 224
First, we confirmed the activity of each recombinant DUB with a UbVS-reactivity assay 225 ( Fig. S5b, c ). All DUBs tested showed almost complete labelling with UbVS, with the exception 226 of USP14 that requires activation by the proteasome 23,37 , which was absent from these in vitro 227 assays. We then proceeded to add each recombinant DUB to extract pre-treated with 228
UbVS/ubiquitin and monitored the stability of 35 S-methionine-labeled ING2, CSNK1E and 229 CRIPT ( Fig.3b ). We chose these proteins as model substrates because they have not been 230 reported to be regulated by DUBs and they have unrelated functions. Extract was treated with 231
UbVS for 30 minutes, instead of 10 minutes, to ensure that the UbVS would react completely 232 with the endogenous DUBs and not inhibit the exogenous DUBs added to the extract (data not 233 shown). We began by assessing all DUBs at the same concentration (800 nM), which is 234 substantially greater than the endogenous concentration for ten of the fourteen DUBs tested ( Fig.  235 S6a). We compared the ability of each DUB to rescue degradation of the selected substrates, 236 creating a "DUB profile" that reports the percentage of substrate rescued by each DUB (Fig. 3b ). 237
We observed that only USP7, USP15, USP25 and USP28 could rescue degradation of these 238 substrates (Fig. 3b, Fig. S6b ). Whereas USP28 and USP15 are present at low concentration in 239 extract (4 and 20 nM respectively), USP25 was not detected in the previous study indicating that 240 its concentration is very low, so its activity was not further evaluated. USP7 is much more 241 abundant in extract (150 nM), suggesting that it might be able to rescue degradation of these 242 substrates at its physiological concentration. In fact, when tested at physiological concentrations, 243 USP7 remained capable of strongly rescuing CRIPT stability, with partial rescue of ING2 244 stability ( Fig.3c, S6c ). In contrast, USP15 and USP28 did not rescue substrate degradation when 245 used at lower concentrations, even though these exceeded their endogenous concentrations by 5-246 to 15-fold, respectively ( Fig. 3c, S6c) . Therefore, among all the DUBs screened, USP7 seemed 247 unique in its ability to rescue degradation of the substrates when tested at its physiological 248 concentration. In contrast, USP4, USP9X, OTUD3, USP8, USP10 and USP21 did not rescue 249 degradation of the three substrates, even though they were tested well above their endogenous 250 concentrations. We were puzzled by the fact that the two known proteasome associated DUBs, 251 UCHL5 and USP14, did not affect degradation of the substrates tested. Because they are very 252 abundant in extract, we retested them together with UCHL3 (another very abundant DUB in 253 extract) at 5 times their endogenous concentration and we compared them to USP7. None of 254 these DUBs had an effect comparable to USP7 in this assay (Fig.3d) . 255
Because USP7, USP15, USP25 and USP28 was each sufficient to stabilize all three 256 substrates when used at 800 nM concentration, we wondered whether these DUBs were also 257 capable of restoring ubiquitin availability in UbVS-treated extracts. We treated extract with 10 258 µM UbVS, added each of the recombinant DUBs and monitored the charging status of Ube2C-259
Ub thioester as a readout of ubiquitin availability. We included USP21 as a positive control, as it 260 broadly deubiquitylates substrates in vitro, as well as USP5, which can regenerate free ubiquitin 261 by acting on unanchored ubiquitin chains 38 . As expected, addition of exogenous ubiquitin fully 262 restored charging of the Ube2C-Ub thioester (Fig.3e) , as did addition of USP21, consistent with 263 its known broad substrate specificity. USP5 did not have any effect, suggesting that free 264 unanchored ubiquitin chains are not generated at high levels in UbVS-treated extract. Of the 4 265
DUBs able to rescue substrate degradation, only USP15 was able to fully restore charging of 266 13 Ube2C. This finding suggests that USP7, USP25 and USP28 have a restricted substrate 267 specificity that is capable of rescuing substrate degradation without impacting ubiquitin 268 availability in the extract, whereas USP15 seems to have a broader specificity that allows it to 269 rescue degradation and also restore ubiquitin recycling. On the other hand, despite the ability of 270 USP21 to regenerate free ubiquitin, it is not able to rescue the degradation of any of the tested 271 substrates. 272
USP7 broadly rescues protein degradation in UbVS/ubiquitin treated extract 273
As USP7 seemed to be the most efficient DUB in rescuing degradation of the substrates 274 tested, we decided to investigate how broad an effect USP7 had in rescuing proteins from 275 degradation in extract treated with UbVS/ubiquitin. We performed a TMT-based quantitative 276 proteomics experiment comparing protein stability in extract treated with UbVS/ubiquitin, and in 277 extract in which USP7, USP9X or USP4 were added at 800 nM each ( Fig. 4a ). We tested USP9X 278 and USP4 as they were good targets of HA-UbVS ( Fig. 3a ) yet were not sufficient to rescue the 279 degradation of the panel of substrates that we tested (Fig 3c) . We found that USP7 could rescue 280 16 of the 20 proteins degraded in UbVS/ubiquitin ( Fig. 4c ). However, we did not find any 281
protein stabilized by addition of USP4 or USP9X (Fig.4b, 4c ), consistent with the results of our 282 earlier screen using the panel of 35 S-labeled substrates. The fact that human recombinant USP7 283 can stabilize endogenous Xenopus proteins suggests again that DUB-dependent regulation of the 284 stability of these proteins is likely evolutionarily conserved. 285
Because USP7 broadly rescued substrate degradation in UbVS/ubiquitin-treated extract 286 ( Fig. 4b, c ) and has been reported to be associated with the proteasome 39,40 , USP7 might inhibit 287 the proteasome independent of its catalytic activity, as is known for USP14 37 . Thus, we tested if 288 14 the catalytic activity of USP7 was required for substrate rescue. Pre-incubation of USP7 with 289
UbVS inhibited rescue of substrate degradation ( Fig.4d ), confirming that deubiquitinating 290 activity of USP7 is required for the rescue. Second, we investigated if USP7 could inhibit 291 degradation of other known proteasome substrates. We tested if USP7 can rescue the APC 292 substrates cyclin B1 and securin from proteasome degradation. Surprisingly, we found that USP7 293 was not able to rescue them from degradation ( Fig. 4e ), indicating that USP7 does not generally 294 inhibit the degradation of all substrates of the UPS. 295 296
Inhibition of Usp7 is not sufficient to induce protein instability suggesting that DUBs 297 function redundantly to control protein stability in extract 298
Because USP7 could stabilize most of the proteins degraded in extracts treated with 299
UbVS/ubiquitin, we tested if inactivation of USP7 using the specific inhibitor XL-188 41 was 300 sufficient to induce degradation of the substrates that we identified. We also tested the effect of 301 USP14 inhibition on proteome stability using the specific inhibitor IU-47 42 alone or in 302 combination with XL-188, since USP14 inactivation promotes degradation of some proteasome 303 substrates in vitro and in human cells 43 . First, we verified these compounds were able to inhibit 304 the endogenous Xenopus DUBs. We pre-incubated extract with the active compounds (IU-47 and 305 XL-188) and the respective inactive derivatives (IU-C and XL-203) for 30 minutes, and then 306 added 10 µM HA-UbVS. As expected, only the active compounds were able to prevent HA-307
UbVS labelling of the specific targeted DUB (Fig. S7a ). After we verified that the inhibitors 308 were working in extract, we compared protein stability in extract pre-treated with 10 µM UbVS, 309 100 µM IU-47 (USP14i), 200 µM XL-188 (USP7i) or the combination of the latter inhibitors, 310
with TMT-based quantitative proteomics (Fig. S7b) . In all conditions we added ubiquitin to 311 15 minimize any impact of DUB inhibition on ubiquitin recycling. In this experiment, we confirmed 312 again that 14 of the 34 candidates (Fig. S7b) were degraded in UbVS/ubiquitin treated extract. 313
Among these proteins, only HN1 was destabilized after specific USP7 inhibition. There were no 314 other proteins (detected with more than one peptide) that were destabilized following specific 315 USP7 inhibition. Inhibition of USP14 did not promote protein instability in Xenopus extract, as 316 none of the proteins degraded in UbVS/ubiquitin, or any other protein, was degraded in IU-47-317 treated extract (Fig. S7c, d ). Inhibition of both DUBs, as expected, caused the degradation of 318 Hn1 that was destabilized by the USP7 inhibitor. In addition, we observed degradation of three 319 other proteins: DBN1, KHLC1, and Supervillin (SVIL), a known USP7 substrate 44 (Fig.S7c,  320 bottom). Together these findings suggest that inhibition of USP7 alone or in combination with 321 USP14 is not sufficient to drive the broader pattern of protein instability that we observe in 322 extracts treated with UbVS/ubiquitin. Instead, our results support a model in which multiple 323
DUBs play redundant functions in maintaining stability of these substrates. 324
Discussion 325
In this study, we discovered novel DUB substrates that are protected from proteasome 326 degradation by cysteine-protease DUBs using a non-biased proteomic approach. One of the 327 challenges in identifying DUB substrates is that DUBs may function redundantly. Here, we 328 circumvented DUB redundancy by inactivating multiple DUBs simultaneously. We took 329 advantage of the Xenopus egg extract model system in which the quality control pathway is 330 silent, as protein synthesis is inhibited. Thus, proteins destabilized by DUB inhibition are more 331 likely to be direct DUB substrates as transcription and translation are suppressed. We 332 recapitulated DUB-dependent stability with recombinant human proteins, indicating that their 333 DUB-dependent regulation is evolutionary conserved. We showed how these novel physiological 334 DUB substrates can be a valuable tool for studying DUB activity and specificity. By testing the 335 ability of individual DUBs to rescue their degradation in a system in which DUBs are broadly 336 inhibited, we found that USP7 has a broad capacity to rescue substrate degradation. However, we 337 found that specific inhibition of USP7 is not sufficient to induce substrate instability, suggesting 338 that stability of the substrates that we identified is likely controlled by multiple DUBs. Together 339 our findings highlight the role of DUB redundancy and the importance of inhibiting multiple 340 DUBs to reveal new DUB substrates. 341
Our approach began with identifying proteins protected from proteasomal degradation by 342 cysteine-protease DUBs. Several of these proteins are known to be regulated by specific DUBs, 343 including MARCH7, BIRC3, STAM, NFX1,TRIP12, SVIL, and NEK2A 29, 30, 32, 45, 31, 44, 46 . 344 Furthermore, PIM3 and WASL have not been connected previously to DUBs, but are similar in 345 sequence to well-established DUB substrates (PIM2 47 and WASH 48 respectively). Together, 346 these findings validate that our approach can identify true DUB substrates. However, the vast 347 majority of the proteins we identified have not been directly implicated as DUB substrates, 348 demonstrating the novelty of our approach. Some proteins that we identified have a proposed 349 physiological function, but have not been deeply studied otherwise, explaining why UPS- UPS substrate and we discovered that cysteine-protease DUBs antagonize its degradation, 360 providing a novel mechanism that regulates its stability. SPRTN and ETAA1 are both involved 361 in DNA replication and DNA damage and are essential for maintaining genome stability 51,52 . A 362 specific mutation in SPRTN causes a syndrome that predisposes patients to cancer (the Ruijs-363 Aalfs syndrome) 53 while ETAA1 (Ewing tumor-associated antigen 1) was discovered as a tumor-364 specific antigen in Ewing's sarcoma 54 . Our results provide the first evidence that the UPS 365 controls the stability of ETAA1. SPRTN is a cell cycle-regulated protein that is known to be 366 ubiquitylated by APC/CDH1 55 and degraded upon exit from mitosis. Our data suggest that 367
UbVS-sensitive DUBs could ensure SPRTN stability during S-phase or during the DNA-damage 368 response when its activity is required. Casein Kinases ε and δ are versatile proteins that 369 participate in multiple processes such as cell cycle control, spindle organization and circadian 370 rhythm 56 . They auto-phosphorylate themselves inhibiting their catalytic activity 57 . Our study 371 suggests that DUBs could modulate their degradation by the UPS as another mechanism to 372 regulate their activity. 373
Our candidate substrates were enriched for ubiquitin ligases (n=12), extending our 374 understanding of the importance of DUBs in counteracting their auto-ubiquitination and 375 consequent degradation 17,33 . Makorin Ring Finger protein 1 (MKRN1) ubiquitylates p53 and p21 376 during cell growth, targeting them to proteasomal degradation 58 . Yet despite intensive study, a 377 role of DUBs in controlling MKRN1 stability has not been described. Our data suggest that 378 autoubiquitination of MKRN1 could be an important control mechanism, as it is for MDM2, 379 another p53 ubiquitin ligase 59 . Among the new substrates we identified, we found multiple 380 transcription factors (n=7) and proteins involved in RNA metabolism (n=12). These data further 381 support the idea that DUBs may regulate these processes 16, 20 and suggest that changes in protein 382 levels observed in growing cells after DUB inhibition must be carefully interpreted as they could 383 be due to an indirect effect induced by changes in transcription/translation. 384
Having identified a set of novel physiological DUB substrates, we next tested the ability 385 of specific DUBs to antagonize their degradation under conditions in which the physiological 386 rates of substrate ubiquitination are maintained. The most interesting finding to emerge from this 387 analysis was the ability of USP7 to rescue a large number of substrates from degradation. USP7 388 has been highly studied and has attracted attention as a pharmacological target, as it regulates the 389 stability of the tumor suppressor p53 and its regulator MDM2 60 . Among the DUBs we tested, 390 USP7 has the greatest number of identified substrates, most of which are targeted to the 391 proteasome 61 . Among the substrates that we identified, a few such as MARCH7, SVIL, NEK2A 392 and TRIP12 are known targets of USP7 29,44,46,45 whereas two others, PIM3 and WASL, are likely 393 19 USP7 targets as USP7 is known to regulate related proteins (PIM2 47 and WASH 48 respectively) 394 in human cells. 395
What explains the broad ability of USP7 to antagonize proteasomal degradation? USP7 396 has been reported to associate with the proteasome 39,40 , where it could intercept proteins that are 397 targeted for degradation. However, the physiological significance and mechanism of this 398 association has not been carefully studied. An intriguing possibility is that USP7 acts on 399 substrates that are insensitive to the other proteasome-associated DUBs, USP14 and UCHL5. For 400 example, USP14 has been shown to deubiquitylate proteins that carry more than one ubiquitin 401 chain 62 . As such, it follows that USP7 could deubiquitylate substrates bearing single ubiquitin 402 chain substrates that are insensitive to USP14. More studies are needed to fully understand the 403 substrate specificity of the proteasome-associated DUBs and the possible role of USP7 in this 404 context. USP7 may have a broad ability to rescue substrates from degradation because it directly 405 binds a wide range of proteins through recognition of common degenerate motifs (P/AxxS and 406 Kxxx/KxK) that are found in many proteins 61 . Another plausible explanation is that USP7 is 407 kinetically fast, and thus competent to counteract the rates of ubiquitination of ubiquitin ligases 408 that target substrates for degradation. This idea is supported by USP7 being the most active DUB 409 in Ub-AMC assays among a panel of 12 cysteine DUBs tested 63 . 410
Despite USP7 being able to broadly rescue substrates from degradation, it was unable to 411 rescue the APC/C substrates Securin and CyclinB1. This result was not due to a lack of activity 412 of USP7 in mitosis because we verified that USP7 was still active in mitosis (data not shown). 413
The insensitivity of these proteins to USP7 could be due to the fact that USP7 is unable to 414 recognize K11-linked ubiquitin and mixed ubiquitin chain types that are synthetized by the 415 20 towards mixed ubiquitin linkages (such as K48/K11) remains unclear. 417
Despite the broad ability of USP7 to rescue substrates from degradation, USP7 was 418 unable to rescue ubiquitin depletion in UbVS-treated extract. In contrast, Usp21 (a highly active 419 and nonspecific DUB) was able to rescue ubiquitin depletion, but was unable to rescue 420 degradation of the tested substrates. These finding suggest that even if USP7 broadly rescues 421 substrates from degradation, it must have a distinct and probably restricted substrate specificity 422 compared to USP21. For example, USP21 may deubiquitylate a limited number of highly 423 abundant proteins present in extract, whereas USP7 may target a distinct set of low abundance 424 proteins. Identifying non-degradative targets of USP7 and USP21 will be an important question 425 to address in future research to better understand the features underlying substrate specificity of 426 these enzymes. 427
Our study suggests that the large number of substrates protected from degradation by 428 USP7 reported in the literature is not simply due to USP7 having been deeply studied, but arises 429 from its broad ability to rescue substrates from degradation. Although many USP7 substrates 430 have been reported, our work suggests that USP7 may contribute to the stabilization of an even 431 larger number of substrates, as the identification of some substrates may have been masked by 432 DUB redundancy. In our system, despite USP7's ability to broadly rescue substrates from 433 degradation, we observed that specific inhibition of USP7 was not sufficient to induce 434 degradation of these substrates. Similar results were obtained for the inhibition of USP14, a 435 proteasome-associated DUB whose inhibition enhances proteasome activity 37 . Even 436 simultaneous inhibition of USP7 and USP14 destabilized very few proteins. Together these 437 findings support the notion that DUBs function redundantly to maintain the stability of the 438 21 proteins in this system. Because degradation is an irreversible step in the protein lifecycle, DUB 439 redundancy may help set a higher threshold for ubiquitination required for degradation of a 440
protein, beyond what is required for direct recognition by the proteasome. Interphase extract was prepared as described 65 but using 2 μg/ml calcium ionophore 459 (A23187, Calbiochem) for egg activation. Entry into mitosis was induced by addition of 1 µM 460 non-degradable cyclin B (MBP-Δ90) as previously described 66 . 461
462

HA-UbVS immunoprecipitation 463
Following treatment with 10 µM HA-UbVS (10 minutes at 24°C), Xenopus extract was 464 diluted three times with XB buffer (10 mM potassium HEPES pH 7.7, 500 mM KCl, 0.1 mM 465 CaCl2, 1 mM MgCl2, 0.5% NP40) and incubated with anti-HA beads or empty beads at 4°C (1h 466 and 30 minutes). At the end of the incubation, beads were washed three times with XB buffer, 467 SDS sample buffer was added and samples were subjected to SDS gel electrophoresis. Samples 468 were processed according to the GeLC-MS/MS strategy 67 . 469
470
HA-UbVS immunodepletion 471
Xenopus extract was pre-treated with 10 µM HA-UbVS (10 minutes at 24°C) diluted 472 three times with XB buffer and incubated with anti-HA beads or empty beads overnight at 4°C. 473
Supernatants from the beads were collected and treated for Mass Spectrometry analysis by SL-474 TMT method (described below). Fisher Scientific). Peptides were separated on a column packed with 35 cm of Accucore C18 524 resin (2.6 μm, 150 Å, Thermo Fisher Scientific). The column had a 100 μm inner diameter 525 microcapillary. For each experiment, 2 μg of peptides were loaded onto this column. Peptides 526 were separated, using a flow rate of 450 nL/min., with a 150-minute gradient of 3 to 25% 527 acetonitrile in 0.125% formic acid. Each analysis used an MS3-based TMT method, which it is 528 known to reduce ion interference if compared to MS2 quantification. The scan sequence starts 529 with an MS1 spectrum (Orbitrap analysis, resolution 120,000, 400−1400 Th, automatic gain 530 control (AGC) target 5E5, maximum injection time 100 ms). For subsequent MS2/MS3 analysis, 531 only the top 10 precursors were selected. MS2 analysis included: collision-induced dissociation 532 26 (CID), quadrupole ion trap analysis, automatic gain control (AGC) 2E4, NCE (normalized 533 collision energy) 35, q-value 0.25, maximum injection time 120 ms), and isolation window at 534 0.7. After we acquire each MS2 spectrum, we collected an MS3 spectrum in which multiple MS2 535 fragment ions were captured in the MS3 precursor population with isolation waveforms using 536 multiple frequency notches. MS3 precursors were fragmented by HCD and analyzed using the 537 Orbitrap (NCE 65, AGC 1.5E5, maximum injection time 150 ms, resolution was 50,000 at 400 538 Th). For MS3 analysis, we used charge state-dependent isolation windows: For charge state z=2, 539 the isolation window was set at 1.3 Th, for z=3 at 1 Th, for z=4 at 0.8 Th, and for z=5 at 0.7 Th. 540
Collected Spectra were processed using a Sequest-based software pipeline. Spectra were 541 converted to mzXML using MS Convert 68 . Database searching included all the entries from the 542 PHROG databas. This database includes many lower abundant proteins and multiple splice 543 isoforms (not present in other databases). In the original study, around 11,000 proteins were 544 identified 24 . Thus, our study (with ~8000 proteins) represents an acceptable coverage of the 545 Xenopus proteome. This database was concatenated with one composed of the sequences in the 546 reversed order. Searches were performed using a 50 Th precursor ion tolerance and the product 547 ion tolerance was set to 0.9 Da. Oxidation of methionine residues (+15.995 Da) and, where 548 indicated. Peptide-spectrum matches (PSMs) were adjusted to a 1% false discovery rate (FDR). 549 PSM filtering was performed using a linear discriminant analysis, as described previously and 550 assembled to a final protein-level FDR of 1%. Proteins were quantified by summing reporter ion 551 counts across all matching PSMs 69 . Reporter ion intensities were adjusted to correct for the 552 isotopic impurities of the different TMT reagents according to manufacturer specifications. The 553 peptides signal-to-noise (S/N) measurements assigned to each protein were summed and 554 normalized so that the sum of the signal for all proteins in each channel was equivalent, thereby 555 27 accounting for equal protein loading. Lastly, each protein was scaled such that the summed 556 signal-to-noise for that protein across all channels was 100, thereby generating a relative 557 abundance (RA) measurement. NFX1  MARCH7  MKRN1  FAM32A  RNASEH1  PIM3  CRIPT  WASL  KIAA1430  RBM18  HN1  RNF138  GTSF1  SYF2  ZNF598  ARHGEF19  ZMAT2  BORA  SOX3  CSNK1E  SOX15  ZFP36L1  BIRC3  EIF1  UBOX5  ETAA1  SPRTN  WEE2  PLIN2  STAM  PLK3  TGIF2  C6ORF132 were expressed in rabbit reticulocyte lysate, labeled with 35 S-methionine and added to the 756 extract, treated as described for the TMT proteomic experiments (Fig.1e ). Aliquots were 757 collected at the indicated times, quenched with SDS sample buffer and processed for SDS-PAGE 758 and phosphorimaging. UbVS/ubiquitin-dependent degradation of these proteins was confirmed 759 in 2 independent experiments. (c) Quantification of one experiment. Quantification of the second 760 experiment is shown in Fig. S3d (d 
